NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) Short Interest Up 35.0% in February

NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) was the recipient of a significant growth in short interest during the month of February. As of February 15th, there was short interest totalling 110,200 shares, a growth of 35.0% from the January 31st total of 81,600 shares. Based on an average trading volume of 235,700 shares, the short-interest ratio is currently 0.5 days.

NovaBay Pharmaceuticals Stock Down 4.0 %

NBY opened at $0.58 on Tuesday. NovaBay Pharmaceuticals has a twelve month low of $0.36 and a twelve month high of $9.08. The firm has a market cap of $2.44 million, a PE ratio of -0.06 and a beta of 2.82.

About NovaBay Pharmaceuticals

NovaBay Pharmaceuticals, Inc develops and sells eyecare and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; Avenova Eye Health Support antioxidant-rich oral supplements; Avenova Lubricating Eye Drops for instant relief; NovaWipes by Avenova; Avenova WarmEye Compress to soothe the eyes; and the i-Chek by Avenova to monitor physical eyelid health.